Heparin-induced type II thrombocytopenia: Response to renewed heparin administration;Heparin-induzierte thrombozytopenie typ II: Re-exposition mit heparin

Deutsche Medizinische Wochenschrift

Volumn 124, Issue 43, 1999, Pages 1267-1270

  Matthies, B ^a   Burger T ^b   Koch, B ^b   Bock M ^b  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; LEPIRUDIN;

AGED; ANTICOAGULATION; ARTERY OCCLUSION; ARTICLE; CASE REPORT; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; THROMBOCYTOPENIA; THROMBOCYTOPOIESIS;

EID: 0033615568     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1024530     Document Type: Article

References (14)

1. 1 Alving, B. M., C. Krishnamurti: Recognition and management of heparin-induced thrombocytopenie (HIT) and thrombosis. Semin. Thromb. Hemostas. 23 (1997), 560-574.
2. 2 Amiral, J., F. Bridey, M. Dreyfuß, A. M. Vissac, E. Fressinaud, E. Wolf, M. Meyer; Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia. Thromb. Haemost. 68 (1992), 95-96.
3. 3 Böck, M., M. U. Heim, W. Brandstädter, H. Peschke: Die Heparin-induzierte Thrombozytopenie: Klinik, Diagnostik. Therapie. Ärztebl. Sachsen-Anhalt 7 (1996), 24-26.
4. 4 Greinacher, A.: Heparin-assoziierte Thrombozytopenien. Diagnose & Labor 43 (1993), 124-129.
5. 5 Greinacher, A., I. Michels, V. Kiefel, C. Mueller-Eckhardt: A rapid and sensitive test for diagnosing heparin-associated thrombocytopenia. Thromb. Haemost. 66/6 (1991), 734-736.
6. 6 Greinacher, A., B. Pötzsch, J. Amiral, V. Dummel, A. Eichner, C. Mueller-Eckhardt: Heparin-associated thrombocytopenia: Isolation of the antibody and characterization of a multimolecular PF4-heparin complex as the major antigen. Thromb. Haemost. 71 (1994), 247-251.
7. 7 Greinacher, A., H. Völpel, B. Pötzsch: Recombinant hirudin in the treatment of patients with heparin-associated thrombocytopenia, type II (HAT). Ann. Hematol. 72, Suppl.I (1996), A92 (Abstract).
8. 8 Kelton, J. G., D. P. Sheridan, A. V. Santos, J. Smith, K. Steeves, C. Smith, W. G. Murphy: Heparin-induced thrombocytopenia: Laboratory studies. Blood 72 (1988), 925-930.
9. 9 King, D. J., J. G. Kelton: Heparin-associated thrombocytopenia. Ann. intern. Med. 100 (1984), 535-540.
10. 10 Nand, S., W. Wong, B. Yuen, A. Yetter, E. Schmulbach, S. G. Fisher: Heparin-induced thrombocytopenia with thrombosis: Incidence, analysis of risk factors, and clinical outcomes in 108 consecutive patients treated at a single institution. Amer. J. Hematol. 56 (1997), 12-16.
11. 11 Peters, U., R. Egbring, G. Fuchs, R. Funck, A. Greinacher, I. Rohner, A. Kröninger, R. Seitz: Aktivierung des Gerinnungs-, Fibrinolyse-und Endothelzellsystems bei vier Patienten mit Heparin-assoziierter Thrombozytopenie (HAT II). Hämostaseologie 15 (1995), 127-131.
12. 12 Warkentin, T. E., M. N. Levine, J. Hirsh, P. Horsewood, R. S. Roberts, M. Gent, J. G. Kelton: Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. New Engl. J. Med. 332 (1995), 1330-1335.
13. 13 Weismann, R. E., R. W. Tobin: Arterial embolism occuring during systemic heparin therapy. Arch. Surg. 76 (1958), 219-227.
14. 14 White, P. W., J. R. Sadd, R. E. Nensel: Thrombotic complications of heparin therapy. Including six cases of heparin-induced skin necrosis. Ann. Surg. 190 (1979), 595-608.